Screening and identification of potential MERS-CoV papain-like protease (PLpro) inhibitors; Steady-state kinetic and Molecular dynamic studies
MERS-CoV belongs to the coronavirus group. Recent years have seen a rash of coronavirus epidemics. In June 2012, MERS-CoV was discovered in the Kingdom of Saudi Arabia, with 2,591 MERSA cases confirmed by lab tests by the end of August 2022 and 894 deaths at a case-fatality ratio (CFR) of 34.5% docu...
Saved in:
Main Authors: | Mohammed Ali Dahhas (Author), Hamad M. Alkahtani (Author), Ajamaluddin Malik (Author), Abdulrahman A Almehizia (Author), Ahmed H. Bakheit (Author), Siddique Akber Ansar (Author), Abdullah S. AlAbdulkarim (Author), Lamees S.Alrasheed (Author), Mohammad A. Alsenaidy (Author) |
---|---|
Format: | Book |
Published: |
Elsevier,
2023-02-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Utilizing sinapic acid as an inhibitory antiviral agent against MERS-CoV PLpro
by: Mudassar Shahid, et al.
Published: (2024) -
Crystal structure of SARS-CoV-2 papain-like protease
by: Xiaopan Gao, et al.
Published: (2021) -
Papain-Like Proteases as Coronaviral Drug Targets: Current Inhibitors, Opportunities, and Limitations
by: Anastasiia I. Petushkova, et al.
Published: (2020) -
Discovery of human coronaviruses pan-papain-like protease inhibitors using computational approaches
by: Mubarak A. Alamri, et al.
Published: (2020) -
Quercetin and Kaempferol as Multi-Targeting Antidiabetic Agents against Mouse Model of Chemically Induced Type 2 Diabetes
by: Muhammad Ali, et al.
Published: (2024)